EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹1,808 Cr | ₹1,480 Cr | ₹1,309 Cr | ₹1,086 Cr | ₹1,125 Cr |
What is the latest Trade Payables ratio of EMCURE PHARMACEUTICALS ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹1,808 Cr |
| Mar2025 | ₹1,480 Cr |
| Mar2024 | ₹1,309 Cr |
| Mar2023 | ₹1,086 Cr |
| Mar2022 | ₹1,125 Cr |
How is Trade Payables of EMCURE PHARMACEUTICALS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,808 Cr | 22.18 | |
| Mar2025 | ₹1,480 Cr | 13.00 | |
| Mar2024 | ₹1,309 Cr | 20.56 | |
| Mar2023 | ₹1,086 Cr | -3.47 | |
| Mar2022 | ₹1,125 Cr | - | |
Compare Trade Payables of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹37,042.7 Cr | -3.1% | 5.7% | 47.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -3.1% |
5.7% |
47.6% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses